<DOC>
	<DOCNO>NCT00793663</DOCNO>
	<brief_summary>The purpose study ad 1 ) measure depth hypnosis assess BIS cAAI average general anesthesia xenon sevoflurane establish reliable monitoring system measure document actual depth hypnosis volatile anesthetic investigate . Ad 2 ) question answer whether 4 mg dexamethasone i.v . effective prophylactic treatment postoperative nausea vomit case xenon sevoflurane anesthesia . Ad 3 ) serf gain evidence ( non- ) effectiveness kinetics ondansetron antiemetic remedy xenon sevoflurane anesthesia .</brief_summary>
	<brief_title>Depth Hypnosis Postoperative Nausea Vomiting During Xenon Anaesthesia</brief_title>
	<detailed_description>1 . Patients include trial randomly allocate either 0.8-1.1 minimum alveolar concentration ( MAC ) xenon 30 % oxygen 0.8-1.1 MAC sevoflurane ( age adapt ) /30 % oxygen . The MAC define therefore applied accord investigated subject ` age . Premedication perform midazolam 7.5 mg orally 45 min induction ( standard dose application form adult clinical practice department ) . Anesthesia induce group propofol 2 mg/kg i.v . remifentanil 0.5 mcg/kg/min infusion 60 s. For tracheal intubation non-depolarizing neuromuscular blocking agent use ( rocuronium 0.6 mg/kg ) . Both group receive remifentanil base rate 0.2 mcg/kg/min . Xenon sevoflurane titrate range 0.8-1.1 MAC accord clinical need base patient 's hemodynamic , autonomic somatic sign . Twenty minute estimate cessation surgical procedure 0.05 mg kg-1 piritramide post anesthetic pain management administer intravenously , well short infusion metamizole 15 mg kg-1 . Depth anesthesia ( hypnosis ) monitor spontaneous EEG ( BIS VISTA , Aspect Medical Systems , Newton , MA ) mid latency auditory evoke potential include monitoring variable indicate patient hypnotic state calculate MLAEP electroencephalogram , composite A-Line ARX Index ( cAAI ) AEP Monitor/2 ( Danmeter A/S , Odense , Denmark ) . Dosing conduct accord current clinical standard without monitoring , thus anesthesia provider blind towards measurement . 2 . After induction anesthesia patient randomized second factor , i.e . 4 mg dexamethasone placebo prevention PONV . To avoid potential imbalance , achieve use factorial design . The application dexamethasone placebo blind investigator assess postoperative nausea vomit . 3 . Patients experience significant nausea randomize receive either 4 mg ondansetron placebo course nausea assess &gt; 32 min . Again , application ondansetron placebo blind investigator assess postoperative nausea vomiting . If symptom postoperative nausea vomit persist 32 min treatment additional rescue treatment offer . Of note , patient able receive rescue treatment time point study demand .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>patient ≥ 18 &lt; 75 year ASA physical status III plan duration anesthesia ≥ 60 minute Apfel score ≥ 23 elective ( laparoscopic ) surgery ( abdominal , gynecological ) woman : highly effective contraception , define method pearl index &lt; 1 ( i.e . hormonal contraceptive , IUD ) history hypersensitivity use drug additive component use preparation stabilization name drug trial history reasonable suspicion malignant hyperthermia and/or degenerative neuromuscular disease , subject observe blood relative history liver function disorder , leucocytosis unclear fever usage halogenated anesthetic . indisposition may aggravate use drug investigate : liver and/or kidney function disorder severe acute chronic infectious disease ( i.e . viral , bacterial , fungal ) elevate intracranial pressure history gastrointestinal ulcer ( ) inflammatory bowel disease severe metabolic disorder hematoporphyria glaucoma hearing disorder disease include airfilled closed cavity , pneumothorax , ileus pregnancy lactation period subject age 18 year ambulatory surgery disease associate requirement high oxygen yield and/or risk high oxygen consumption : severe lung and/or airway disease coronary heart disease and/or seriously impaired cardiac function severe psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Xenon</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Postoperative Nausea vomiting</keyword>
	<keyword>Depth anaesthesia</keyword>
</DOC>